Merck & Co., Inc.
NYSE:MRK · New York Stock Exchange
-$1.32 today
Vol 12.17M · Avg 11.85M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+46.80%
Period High
$122.30
Period Low
$75.59
Latest
$113.87
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Novartis AG
NYSE:NVS
$281.44B
AstraZeneca PLC
NYSE:AZN
$271.19B
Novo Nordisk A/S
NYSE:NVO
$191.33B
Amgen Inc.
NASDAQ:AMGN
$180.82B
Thermo Fisher Scientific Inc.
NYSE:TMO
$172.99B
Abbott Laboratories
NYSE:ABT
$153.34B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.51B
Pfizer Inc.
NYSE:PFE
$143.80B
GSK plc
NYSE:GSK
$101.97B
Sanofi
NASDAQ:SNY
$101.45B
What is the latest MRK filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does MRK have?
Intrinsic Alpha currently shows 20 recent filings for MRK.
Explore More
Continue the stock analysis
Jump to another research area for this company.